BIEI Stock UPDATES Premier Biomedical (BIEI) 0.1550 09/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Premier Biomedical (BIEI) 0.1550 $BIEI

Premier Biomedical Announced the Addition of Dr David Vigerust to Their Scientific Advisory Board
GlobeNewswire - Mon Aug 18, 7:40AM CDT
Premier Biomedical, Inc. (OTC-BB: "BIEI" announced the addition of Dr David Vigerust to their Scientific Advisory Board effective immediately. Dr Vigerust will report to the Chairman of the Scientific Advisory Board and co-founder of the Corporation, Dr. Mitchell S. Felder.

Premier Biotechnology & Anti-CTLA4
ACCESSWIRE - Mon Aug 18, 7:02AM CDT
Whitefish, MT / August 18, 2014 / Many forms of cancer are characterized by a lack of cellular apoptosis (e.g. cell death) and down-regulation of the immune system. In the case of the latter, cytotoxic T lymphocytes ("CTLs" are largely responsible for recognizing and killing cancer cells, but there are some inhibitory mechanisms that interrupt the destruction and prevents cancer cells from being targeted and destroyed.

Promising Medical Breakthroughs by Premier Biomedical, Inc.(BIEI)
GlobeNewswire - Tue Jul 29, 6:47AM CDT
Uptick Newswire sat with President and CEO of Premier Biomedical Inc., Mr. William A. Hartman, to get the scoop on their medical miracles that are stretching scientific limits. Based in El Paso Texas., Premier Biomedical Inc. is working closely with the US Department of Defense with Center of Expertise at the William Beaumont Army Medical Center and the University of Texas at El Paso (UTEP) in high hopes of creating a brighter future for those that have little hope of seeing that future today.

Premier Biomedical Gears Up for Two Important Clinical Trials
ACCESSWIRE - Fri Jul 25, 7:04AM CDT
Whitefish, MT / July 25, 2014 / Premier Biomedical Inc. (OTC: BIEI), a biopharmaceutical company focused on developing and commercializing innovative therapies targeting cancer, traumatic brain injury, Alzheimer's disease, MS and other serious conditions, recently announced that the William Beaumont Army Medical Center ("WBAMC" has begun drafting a protocol that it plans to submit to their Institutional Review Board overseeing its double-blind clinical trial of Feldetrex(tm) in mid-August.

Premier Biomedical, Inc. (BIEI) Retains Porter, LeVay and Rose as Investor Relations Council
GlobeNewswire - Thu Jul 24, 6:47AM CDT
Premier Biomedical, Inc. (OTCBB: "BIEI" a biopharmaceutical company focused on developing and commercializing innovative treatment therapies for cancer, traumatic brain injury, Alzheimer's disease, and other afflictions announced today that it has retained the investor relations firm Porter, LeVay and Rose to represent it and to implement its communications strategies.

Premier Biomedical, Inc. (BIEI) Announces Important Patent Award for a Potential Multi-Billion Dollar Drug for the Treatment of Fibromyalgia and Neuralgia
Business Wire - Mon Jun 30, 7:01AM CDT
Premier Biomedical, Inc. (OTCBB: "BIEI" a biopharmaceutical company focused on developing and commercializing innovative immune system manipulation therapies for breast cancer, Alzheimer's disease, multiple sclerosis (MS), traumatic brain injury (TBI), and others today announced that the United States Patent Office approved a patent on their proprietary medication "Feldetrex (TM)", which is designed to relieve the symptoms of neuropathic pain and fibromyalgia. The William Beaumont Army Medical Center Principal Investigator is drafting a protocol to conduct a double-blind, placebo-controlled comparison of this medication and the leading FDA-approved regimen for these concerns and will be submitting it for IRB approval in the near future.

Premier Biomedical Releases Anti-CTLA4 Market Study
Business Wire - Tue Jun 17, 7:02AM CDT
Premier Biomedical Inc. (OTCBB: BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune system manipulation therapies for breast cancer, as well as potential novel therapies for Alzheimer's disease, multiple sclerosis ("MS" , and traumatic brain injury ("TBI" , today announced the release of a market study conducted by Penn Biotech Group Healthcare Consulting ("PBG" discussing its breast cancer treatment.

Premier Biomedical Continues Progress on Anti-Cancer Treatment
Business Wire - Wed Apr 02, 7:03AM CDT
Premier Biomedical, Inc. (OTCBB:BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune-system manipulation therapies, has prepared and will file a provisional patent application for an anti-breast cancer treatment methodology protocol, in conjunction with its partners in R&D at the Department of Defense (DOD) with Center of Expertise at the William Beaumont Army Medical Center and the University of Texas at El Paso (UTEP) covering its study accepted for presentation at the American Association for Cancer Research (AACR) annual convention April 7-8, 2014 in San Diego. In addition, the group has discovered and will initiate an accelerated development program on two additional anti-cancer drug methodology protocols that it believes are unique in the industry and very promising.

Premier Biomedical to design clinical trial equipment in partnership with Printed Device Concepts
M2 - Thu Mar 27, 5:55AM CDT
Biopharmaceutical company Premier Biomedical (OTCBB:BIEI) revealed on Wednesday the launch of an agreement to design and fabricate its patent-pending Sequential Dialysis Machine that is critical to advancing its medications and procedures via anticipated clinical trials beginning as early as this calendar year.

Premier Biomedical Signs Agreement To Design Equipment For Clinical Trials
Business Wire - Wed Mar 26, 7:01AM CDT
Premier Biomedical, Inc., (OTCBB: BIEI) a biopharmaceutical company focused on developing and commercializing innovative immune-system manipulation therapies, has signed an agreement with Printed Device Concepts, Inc. (PDC) of El Paso, TX to design and fabricate a patent-pending Sequential Dialysis Machine that is critical to advancing the corporation's medications and procedures via anticipated clinical trials beginning as early as this calendar year. Premier has filed over a dozen pending provisional patent applications in the United States and the E.U. addressing a number of diseases previously regarded as incurable or "difficult", such as breast cancer, Alzheimer's disease, ALS, multiple sclerosis (MS), and traumatic brain injury (TBI). Design progress meetings between Premier Biomedical, Inc. (PBI) and Printed Device Concepts are being held coincident with PBI's other R&D partners, the Department of Defense with Center of Expertise at the William Beaumont Army Medical Center (WBAMC) and the University of Texas at El Paso (UTEP).

Premier Biomedical Announces Payoff of Liabilities; Funding for Research and Development
Marketwire - Wed Mar 12, 7:16AM CDT
Premier Biomedical, Inc. (OTCQB: BIEI) a biopharmaceutical company focused on developing and commercializing innovative immune-system manipulation therapies for breast cancer, as well as potential novel therapies for Alzheimer's disease, multiple sclerosis (MS), and traumatic brain injury, announced today that through its equity funding arrangement with Kodiak Capital Group, LLC, which was announced in December 2013, it has paid all its liabilities and anticipates having sufficient capital to fund current on-going and mid-term research and development.

Premier Biomedical to Present Positive Pre-Clinical Breast Cancer Study at American Association for Cancer Research Annual Meeting
Marketwire - Wed Feb 26, 7:15AM CST
Premier Biomedical, Inc. (OTCQB: BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune-system manipulation therapies for breast cancer, as well as potential novel therapies for Alzheimer's disease and traumatic brain injury, announced today that Premier Biomedical will present significantly positive results from duplicated testing on mice at the American Association for Cancer Research annual meeting in San Diego, California on April 5-9, 2014. The results demonstrated statistically significant improvements in survival and a prevention of breast cancer in mice treated with Premier Biomedical's anti-breast cancer treatment compared to both chemotherapy and a non-treated control group.

Premier Biomedical Met With NFL and NCAA Representatives During Super Bowl Week at Coalition for Concussion Treatment Summit at the United Nations
Marketwire - Thu Feb 13, 7:15AM CST
Premier Biomedical, Inc. (http://www.premierbiomedical.com/) (OTCQB: BIEI) today released the following statement regarding their participation in the Coalition for Concussion Treatment (#C4CT) Summit established by Brewer Sports International (http://www.brewersports.com/) (BSI) during Super Bowl Week at the United Nations Headquarters in New York City. The conference followed the announcement that Brewer Sports International and Premier Biomedical have entered into a long-term strategic partnership agreement to continue to explore innovative treatment methods for Traumatic Brain Injury (TBI) and other neurological diseases.

CEO CFO Magazine Interviews Premier Biomedical's CEO Hartman; Second Time in 16 Months
Marketwire - Tue Feb 11, 7:15AM CST
Premier Biomedical, Inc. (OTCQB: BIEI) (OTCBB: BIEI) today announced that President and Chief Executive Officer, William A. Hartman, was recently interviewed for a second time in 16 months by CEO/CFO Magazine, an independent investment publication which conducts interviews with company CEOs. The latest William Hartman interview appears in the publication's Biotechnology and Pharmaceuticals Report available by calling (570) 851-1745 or via CEO/CFO Magazine Online (http://www.ceocfointerviews.com). (The original interview was in the October, 2012 edition.)

Premier Biomedical Advances Vs Head Trauma
Marketwire - Wed Jan 22, 7:02AM CST
Premier Biomedical, Inc. (OTCQB: BIEI) today released the following statement regarding advances in the treatment of Head Trauma. There has been considerable news lately related to professional sports and the incidence rate of head trauma, also referred to as Traumatic Brain Injury, and its lasting effects on clinical depression, suicide/violence ideation, PTSD and longer term, persistent neurological diseases such as Parkinson's Disease, Alzheimer's Disease, and Amyotrophic Lateral Sclerosis (ALS). The scope of the problem is revealed by lesser known statistics published by the Veterans Administration, indicating suicide rates among active-duty personnel are almost one per day. If we include veterans, the number of suicides jumps to almost ONE PER HOUR. This is a huge morale problem and one that demands our collective utmost attention.

MTS Systems and Chery Automobile Company Celebrate The Opening of Their Joint Vehicle System Engineering Laboratory In China
PR Newswire - Thu Jan 09, 5:40PM CST
MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems and position sensors, today announced the grand opening of a vehicle system engineering laboratory in collaboration with Chery Automobile Co. Ltd. in Wuhu, China. The first MTS joint laboratory with a domestic Chinese automotive OEM, the Chery-MTS lab is a center for system and full-vehicle testing applications, as well as the development of new testing technologies.

Premier Biomedical Inc enters into USD5m equity funding with Kodiak Capital Group LLC
M2 - Tue Dec 17, 5:35AM CST
Biopharmaceutical company Premier Biomedical Inc (OTCBB:BIEI) revealed on Monday the execution of a USD5m common stock purchase agreement with Kodiak Capital Group LLC.

Premier Biomedical Secures $5 Million Equity Funding From Kodiak Capital Group, LLC
Marketwire - Mon Dec 16, 7:01AM CST
Premier Biomedical, Inc. (OTCBB: BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune-system manipulation therapies for breast cancer, as well as novel therapies for Alzheimer's disease and traumatic brain injury, announced that it has entered into a $5 million common stock purchase agreement with Kodiak Capital Group, LLC, a Newport Beach-based institutional investor. The company has agreed to file a registration statement with the U.S. Securities & Exchange Commission ("SEC" covering the shares that may be issued to Kodiak under the terms of the common stock purchase agreement. After the SEC has declared the registration statement related to the transaction effective, the company has the right at its sole discretion over a period of one year to sell up to $5 million of common stock under the terms set forth in the agreement.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

NetEase Margins Hold Firm as Game Revenue Slips Again

Updated Category News Views 123

A game publisher can look tired at the top line and still be doing plenty right underneath the hood. NetEase’s third-quarter 2026 report is that kind of animal: revenue eased, yet costs behaved, profit rebounded from the prior quarter, and the balance sheet remains absurdly well stocked. For investors in NASDAQ:NTES, this was not a clean victory lap. It was a reminder...

Continue Reading
Gene Editing’s Steady Revenue Engine Is Taking Shape

Updated Category News Views 112

Gene editing is finally starting to look less like a science-fair moonshot and more like a working supply chain. That distinction matters. The latest market estimate puts the global gene editing market at $5.23 billion in 2026 and projects $8.49 billion by 2031, a 10.1% compound annual growth rate. Respectable growth, certainly, but the real investment story is not a...

Continue Reading
Shanghai Import Expo Draws 4,000 Global Companies Again

Updated Category News Views 175

Shanghai spent last week making a rather pointed commercial argument: China wants to be seen buying, not merely selling. The ninth China International Import Expo, or CIIE, brought together more than 4,000 overseas companies and participants from 162 countries, regions and international organizations. That is a serious gathering by any reasonable measure, even if the...

Continue Reading
Würk's Bryte AI Targets Payroll's Costly Friction Points

Updated Category News Views 104

Payroll mistakes are the sort of paper cuts that suddenly turn into a hospital bill for an employer. Würk’s Nov. 19 launch of Bryte AI goes straight at that ugly reality in cannabis, beverage alcohol, and other heavily regulated workplaces, where a bad time entry, missed document, or misunderstood policy can create a far more expensive mess than ordinary office...

Continue Reading
Greenberg Traurig Builds Real Estate Bench Further

Updated Category News Views 47

Two real estate lawyers rarely move a market, but they can tell you where the legal work is getting sticky. Greenberg Traurig’s November 19 addition of Steven A. Fein and Kelsey Thayer is not some grand macroeconomic pronouncement, and nobody should pretend otherwise. It is, however, a pretty sensible read on the messy corners of commercial property finance: joint...

Continue Reading
CustomerInsights.AI Fast 500 Nod Tests Its AI Model

Updated Category News Views 44

Pharma’s analytics mess is exactly where CustomerInsights.AI has chosen to make its stand. The Scottsdale company’s inclusion in Deloitte’s 2026 Technology Fast 500, announced November 19, is a useful signal that its pitch is finding buyers: life-sciences businesses want AI to do actual commercial work, not sit in a lab demo collecting dust. Still, a Fast 500 badge...

Continue Reading
Securitize Tests the IPO Clock With Anthropic Tokens

Updated Category News Views 93

Anthropic did not even get a full trading day to itself before the tokenization crowd arrived. Securitize says Anthropic stock became available through Securitize Stocks on Solana on the company’s first day as a public company, a loud little signal that the old IPO playbook is being prodded from the edges. For investors, this is not merely another crypto-flavored...

Continue Reading
SDG&E's 21-Year Reliability Run Has Real Investor Weight

Updated Category News Views 37

Seventy minutes without power in a year is the sort of number most people ignore until their refrigerator quits humming. For San Diego Gas & Electric customers, though, it is a meaningful operating result: roughly 70 minutes annually from unplanned outages, on average, over the past decade, alongside fewer than one sustained outage per customer each year. SDG&E has also...

Continue Reading
Bella Rio's Proposed Preferred B Share Giveaway Plan

Updated Category News Views 46

A founder handing over two million of his own common shares is the sort of detail that makes investors stop stirring their coffee. Bella Rio Consulting, the company behind ROCK'N Vodka and Bella Rio Bourbon, says co-founder and Vice President Andy Roiniotis proposes to contribute 2,000,000 personally held Common shares for reclassification into Preferred Series B shares....

Continue Reading
Stanford Forum Puts Industrial AI in the Real World

Updated Category News Views 166

Factory Data Is Not a Free Lunch A factory dataset is worth precisely nothing if its owner cannot control it. That was the hard-nosed thread running through the ASI City Forum at Stanford on November 17: industrial AI is not just about smarter models or splashy chip announcements. It is about whether manufacturers will trust a system with proprietary operating data,...

Continue Reading

Top 5 Most Recently Viewed Articles

Alvopetro Energy Ltd. Reports Record Sales Volumes

Updated Category News Views 127

Alvopetro Energy Ltd. Reports Strong Sales Volumes Alvopetro Energy Ltd. has reported commendable sales volumes for June 2025, reaffirming its position in the energy sector. The company, identified by its ticker symbols ALV (on the TSX Venture Exchange) and ALVOF (on the OTCQX), indicated a notable production rate of 2,514 barrels of oil equivalent per day (boepd) based...

Continue Reading
Mannatech Achieves New Stock Milestone with 52-Week High

Updated Category News Views 177

Mannatech Reaches Remarkable Peak in Stock Performance Mannatech, Incorporated (MTEX), a company dedicated to offering global wellness solutions, has recently achieved a noteworthy milestone by reaching a 52-week high with its stock price hitting $13.34. This impressive rise indicates a substantial increase in investor confidence, as the shares have surged by an...

Continue Reading
Exciting Developments Ahead for FAIRWOOD's Second Season

Updated Category News Views 240

FAIRWOOD Returns with a New Season The popular comedy series FAIRWOOD has officially been renewed for a second season, much to the delight of its fans. The show's creators, renowned musical duo Rusty and Clark Fairwood, along with the talented showrunner Bud Schaetzle, are back at the helm to deliver more engaging episodes. With all six episodes of the first season now...

Continue Reading
Celebrating Pioneers in the $6.8 Trillion Wellness Movement

Updated Category News Views 330

Leaders Transforming the Global Wellness Economy The Global Wellness Summit (GWS), renowned for gathering visionaries in the $6.8 trillion wellness economy, recently wrapped up its 19th annual conference held at an upscale venue. This prestigious gathering celebrated outstanding contributions through the Global Wellness Awards, recognizing individuals who have made...

Continue Reading
CRED iQ & TractIQ Push $50B of Data into AI Era

Updated Category News Views 5

AI-Driven Innovation in Self-Storage Market Mark my words, folks, the marriage of data and AI is reshaping industries faster than a stock split on Wall Street. CRED iQ and TractIQ are venturing into this fast-paced union. Just north of Philadelphia, CRED iQ has sealed a deal with TractIQ, a frontrunner in self-storage data solutions, to funnel a cool $50 billion worth of...

Continue Reading